CPG researchers were awarded US Patent 8076387 for a process of making a highly crosslinked polyethylene for biomedical applications with improved oxidation resistance. This patent is available for license.
Cambridge Polymer Group is pleased to announce implementation of our new document control system as part of our ongoing improvement of our quality system. This DCS is 21CFR compliant and allows us to electronically sign and issue reports and protocols. Clients will soon see changes in the form of electronically signed and verified reports.
CPG scientists presented several studies on the use of antioxidants in medical grade plastics at AMI's conference on medical grade polymers in Philadelphia on September 13-14th.
Each year, the International Society for Technology in Arthroplasty awards the HAP Paul Award to the best paper outlining new developments in the field of arthroplasty. This year, the award will be presented to researchers at the Massachusetts General Hospital and Cambridge Polymer Group for their work on active oxidation stabilization techniques for highly crosslinked UHMWPE. The award will be presented in the October ISTA conference.
The FDA will be hosting a public workshop on the Reprocessing of Reusable Medical Devices on June 8th and 9th in Silver Springs, MD. The purpose of the workshop is to discuss factors affecting reprocessing quality, device design as it relates to reprocessing reusable medical devices, reprocessing methodologies, validation methodologies, healthcare facility best practices, and FDA’s plans to address the identified issues. CPG researcher Stephen Spiegelberg is an invited speaker at the workshop. Further information and registration details can be found by following the link below.
Dr. Gavin Braithwaite gave an invited presentation to the Physics Department at the University of Memphis, discussing research projects conducted at Cambridge Polymer Group over the years.
Dr. Gavin Braithwaite gave a plenary talk at the University of Birmingham, where he discussed the latest advances in biomedical materials. A copy of the abstract is below.
The US Patent Office allowed a patent submitted by CPG researcher Stephen Spiegelberg for an antioxidant-stabilized polyethylene for biomedical applications. The technology was jointly invented by researchers at Cambridge Polymer Group and Massachusetts General Hospital.
ASTM has published a new standard on medical device cleanliness testing procedures. This standard, ASTM F2847: Standard Practice for Reporting and Assessment of Residues on Single Use Implants, describes how to test for manufacturing residues on single use devices, and how the data should be reported. Please contact CPG for more information.